Immunohistochemistry with this TERT-specific antibody could not play the diagnostic surrogate for TERT promoter mutations, but we could find an unexpected increase in TERT immunoreactivity across all types of gliomas and tumor vasculature. Here, TERT is linked to central nervous system cancer.